| 4758 |
Centers for Disease Control and Prevention |
Html |
en |
The influence of school policies on smoking prevalence among students in grades 5-9, Canada, 2004-2005. |
null |
| smoking rates | 0.613346 |
| student smoking | 0.667689 |
| overall smoking prevalence | 0.581228 |
| school tobacco policies | 0.658572 |
| higher smoking prevalence | 0.605547 |
| smoking status | 0.72369 |
| smoking prohibition | 0.600377 |
| health region smoking | 0.577444 |
| school tobacco policy | 0.550785 |
| school smoking policies | 0.890673 |
| student smoking status | 0.603064 |
| smoking uptake | 0.557574 |
| adolescent cigarette smoking | 0.541607 |
| student smoking rates | 0.561705 |
| lower school smoking | 0.608203 |
| Youth Smoking Survey | 0.646096 |
| smoking behavior | 0.71933 |
| smoking control policies | 0.574615 |
| individual smoking behavior | 0.579039 |
| clear smoking rules | 0.546929 |
| smoking prevalence | 0.888648 |
| smoking attitudes | 0.546378 |
| higher school smoking | 0.598658 |
| Manske S. Smoking | 0.542952 |
|
| adolescent smoking behaviours | 0.541302 |
| adolescent smoking | 0.554951 |
| mean smoking prevalence | 0.581197 |
| school smoking policy | 0.671156 |
| smoking | 0.943614 |
| student smoking behavior | 0.569027 |
| smoking varies | 0.548819 |
| smoking behaviors | 0.638579 |
| higher smoking rates | 0.552159 |
| smoking bans | 0.558719 |
| Santana Y. Smoking | 0.539808 |
| school policies | 0.570853 |
| smoking policy characteristics | 0.574717 |
| student smoking behaviors | 0.593737 |
| youth smoking behavior | 0.551939 |
| individual smoking status | 0.689987 |
| youth smoking trajectories | 0.548964 |
| youth smoking | 0.648009 |
| tobacco policy | 0.61486 |
| lower smoking rates | 0.55058 |
| school smoking prevalence | 0.880344 |
| lower smoking prevalence | 0.622049 |
| tobacco control | 0.62205 |
| youth cigarette smoking | 0.546137 |
|
CLICK HERE |
| 5642 |
Centers for Disease Control and Prevention |
Html |
en |
Vinyl chloride - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 6397 |
Centers for Disease Control and Prevention |
Html |
en |
Recommended Adult Immunization Schedule --- United States, 2011 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| recent Td-containing vaccine | 0.657342 |
| Vaccine Injury Compensation | 0.630701 |
| Tdap vaccine | 0.652571 |
| vaccine efficacy | 0.625153 |
| sickle cell disease | 0.627217 |
| quadrivalent vaccine | 0.645414 |
| recent Td vaccination | 0.607626 |
| high-dose influenza vaccine | 0.667403 |
| bivalent vaccine | 0.659075 |
| influenza vaccine | 0.712045 |
| hepatitis A vaccine | 0.620497 |
| live-virus vaccine | 0.626033 |
| Vaccine Adverse Event | 0.630035 |
| diphtheria-containing vaccine | 0.63176 |
| vaccine HPV types | 0.661156 |
| Single-antigen vaccine formulations | 0.635255 |
| vaccination footnote | 0.617298 |
| complement component deficiencies | 0.627731 |
| persons | 0.738927 |
| dose | 0.708382 |
| adult immunization schedule | 0.625774 |
| mumps vaccine | 0.637703 |
| pneumococcal polysaccharide vaccine | 0.666545 |
| single dose | 0.613604 |
|
| vaccination | 0.667411 |
| meningococcal vaccine | 0.70111 |
| doses | 0.623821 |
| HPV vaccination | 0.606608 |
| adults | 0.677279 |
| persistent complement component | 0.628088 |
| HPV vaccine types | 0.701047 |
| standard influenza vaccine | 0.663597 |
| vaccine status | 0.632488 |
| health-care personnel | 0.649255 |
| inactivated vaccine | 0.646349 |
| meningococcal conjugate vaccine | 0.757257 |
| zoster vaccine | 0.628755 |
| measles vaccine | 0.637766 |
| hepatitis B vaccine | 0.650174 |
| Hib vaccine | 0.658869 |
| vaccine series | 0.679411 |
| single-antigen varicella vaccine | 0.662155 |
| influenza vaccination | 0.626128 |
| vaccine | 0.923154 |
| vaccine component sections | 0.657799 |
| attenuated influenza vaccine | 0.664023 |
| health-care facility | 0.610934 |
| MMR vaccine | 0.714879 |
|
CLICK HERE |
| 10073 |
Centers for Disease Control and Prevention |
Html |
en |
NIOSH Program Portfolio : Dermal Diseases : Projects |
The mission of the NIOSH research program for Immune, Dermal & Infectious Diseases is to eliminate occupational injuries, illnesses, and fatalities among workers in these industries through a focused program of research and prevention. Primary efforts are focused on hazard identification since when potential hazards are recognized, work-related dermal and immune diseases can often be prevented or their effects minimized. |
| Information Division component | 0.347294 |
| significant dermal effects | 0.466903 |
| exposure assessment methods | 0.338725 |
| exposure assessment | 0.344485 |
| dermal toxicity | 0.389146 |
| hazardous chemicals | 0.360768 |
| Occupational Research Agenda | 0.413707 |
| NORA DERP | 0.375341 |
| additional dermal hazards | 0.428092 |
| new project leadership | 0.362821 |
| chemicals | 0.375333 |
| deleterious dermal exposures | 0.425901 |
| Health Effects Laboratory | 0.679831 |
| systemic toxicity | 0.344249 |
| allergic skin sensitization | 0.346225 |
| occupational skin disease | 0.347299 |
| dermal program | 0.39386 |
| Dermal Exposure Research | 0.597586 |
| health effects | 0.733804 |
| Effects Laboratory Division | 0.683367 |
| toxic chemicals | 0.363664 |
| Information Division | 0.449708 |
| dermal penetration | 0.375003 |
| Project contact | 0.907172 |
|
| NIOSH Research Projects | 0.38254 |
| Project period | 0.939514 |
| Dermal Resource Guide | 0.473748 |
| dermal risk management | 0.411171 |
| adverse health effects | 0.626394 |
| Dermal Cross-Sector Team | 0.430647 |
| new skin notations | 0.348724 |
| Scott Dotson | 0.51624 |
| chemical protective clothing | 0.366759 |
| dermal exposures | 0.43252 |
| National Occupational Research | 0.417897 |
| dermal application | 0.378133 |
| occupational skin diseases | 0.377595 |
| skin notations | 0.601948 |
| allergic contact dermatitis | 0.459626 |
| occupational skin exposures | 0.440595 |
| Exposure Research Program | 0.45321 |
| NIOSH technical document | 0.341732 |
| new NIOSH strategy | 0.336171 |
| dermal exposure | 0.690979 |
| occupational dermal exposure | 0.571479 |
| Gary S. Dotson | 0.396733 |
| forth NIOSH policies | 0.353617 |
| improved skin notations | 0.344399 |
|
CLICK HERE |
| 10780 |
Centers for Disease Control and Prevention |
Html |
en |
Recent Outbreaks and Incidents' CDC |
CDC’s Recent Outbreaks and Incidents Web page informs on current public health emergency topics including diseases, infections, and natural disasters. |
| ATSDR staff | 0.559456 |
| Hurricane Maria | 0.442463 |
| CDC | 0.787583 |
| Zika infection | 0.259991 |
| Hurricane Irma | 0.666703 |
| Emergency Operations Center | 0.828482 |
| latest updates | 0.2799 |
| travel notices | 0.259319 |
| Zika | 0.311883 |
| aftermath | 0.211679 |
|
| U.S. government activities | 0.813024 |
| tropical storms | 0.537183 |
| Current Outbreak List | 0.432402 |
| Guillain-Barré syndrome | 0.261689 |
| hurricanes | 0.207095 |
| New page | 0.279383 |
| birth defect | 0.260722 |
| Hurricane Harvey | 0.665903 |
| Virus Disease Outbreak | 0.434179 |
|
CLICK HERE |
| 11110 |
Centers for Disease Control and Prevention |
Html |
en |
2008 National Report on Biochemical Indicators of Diet and Nutrition - Table 3.3 |
null |
| Selenium Serum selenium | 0.345318 |
| Total population | 0.307234 |
| Search Form Controls | 0.415143 |
| Males | 0.374921 |
| Serum alpha-carotene | 0.310124 |
| conf. interval | 0.725178 |
| Urinary equol | 0.305333 |
| file | 0.351066 |
| Serum iron | 0.309861 |
| Geometric mean | 0.717823 |
| small cell size | 0.394947 |
| Urinary enterolactone | 0.305092 |
| Urinary O-desmethylangolensin | 0.305253 |
| Carotenoids Serum | 0.306805 |
| u.s. population | 0.527661 |
| Serum lutein/zeaxanthin | 0.310044 |
| Nutrition Examination Survey | 0.675207 |
| Biochemical Indicators | 0.318965 |
| National Report | 0.311645 |
| Tweet Share Compartir | 0.324753 |
| Urinary enterodiol | 0.305172 |
| iron-binding capacity | 0.90582 |
| Mexican Americans | 0.385923 |
|
| percentiles | 0.350238 |
| greater uncertainty | 0.315395 |
| non-hispanic whites | 0.375738 |
| Table | 0.366377 |
| Serum trans-lycopene | 0.310017 |
| Iodine Urinary iodine | 0.303089 |
| Lignans Urinary genistein | 0.306749 |
| page options Skip | 0.318764 |
| Search Controls | 0.313898 |
| Serum gamma-tocopherol | 0.310151 |
| non-hispanic blacks | 0.383533 |
| Iron-Status Indicators Serum | 0.346051 |
| Serum trans-beta-carotene | 0.310097 |
| total U.S. population | 0.320859 |
| National Health | 0.464685 |
| Compounds Serum folate | 0.348717 |
| Urinary daidzein | 0.305414 |
| Serum transferrin saturation | 0.35065 |
| Serum vitamin | 0.338446 |
| page | 0.346231 |
| serum | 0.748211 |
| serum concentrations | 0.509586 |
|
CLICK HERE |
| 12202 |
Centers for Disease Control and Prevention |
Html |
en |
Addressing Ebola Virus Infection Concerns in K-12 Schools:Interim Guidance for District and School Administrators | EbolaHemorrhagic Fever | CDC |
null |
| Ebola exposure risk | 0.295894 |
| individual risk assessment | 0.346736 |
| ill person | 0.275993 |
| Ebola infection | 0.327549 |
| Ebola disease | 0.274605 |
| Ebola virus transmission | 0.288439 |
| public health authority | 0.269604 |
| public health authorities | 0.970416 |
| ebola virus | 0.363174 |
| Ebola symptoms | 0.282757 |
| widespread transmission | 0.259687 |
| exposure risk category | 0.245277 |
| school | 0.346729 |
| civil rights | 0.246535 |
| civil rights laws | 0.236708 |
| possible Ebola infection | 0.287564 |
| public health department | 0.244993 |
| education records | 0.256314 |
| temporary school dismissal | 0.236166 |
| body fluids | 0.285633 |
| direct active monitoring | 0.236669 |
| possible Ebola exposure | 0.327107 |
| person | 0.347045 |
| Ebola risk | 0.288109 |
|
| ebola transmission | 0.290172 |
| educators | 0.334194 |
| Ebola | 0.608334 |
| active monitoring | 0.292567 |
| public health restrictions | 0.240524 |
| Ebola virus disease | 0.289199 |
| United States | 0.281693 |
| Ebola exposure | 0.41056 |
| public health recommendations | 0.240252 |
| Contact public health | 0.239821 |
| immediate public health | 0.241946 |
| Federal civil rights | 0.237232 |
| Ebola risks | 0.271587 |
| K-12 schools | 0.242125 |
| Ebola plan | 0.275994 |
| public health investigation | 0.237033 |
| public health actions | 0.319159 |
| Ebola Guidance | 0.274119 |
| staff | 0.24941 |
| possible public health | 0.240255 |
| Ebola Virus Exposure | 0.293677 |
| personally identifiable information | 0.279079 |
| people | 0.242399 |
| local public health | 0.331621 |
|
CLICK HERE |
| 13956 |
Centers for Disease Control and Prevention |
Html |
en |
Child Development, Home |
null |
| health professionals | 0.91738 |
| development | 0.329643 |
| symptoms checklist | 0.986798 |
| Parents | 0.311015 |
| danger | 0.3941 |
| life | 0.3324 |
| example | 0.353242 |
|
| children | 0.741849 |
| partners | 0.307714 |
| crawling | 0.453224 |
| educators | 0.368102 |
| milestones | 0.407083 |
| potential | 0.305175 |
|
CLICK HERE |
| 16025 |
Centers for Disease Control and Prevention |
Html |
en |
New CDC Vaccine Effectiveness Study Uses Innovative Approach to Measure Vaccine Benefits |
CDC researchers compared genetic properties of circulating H3N2 viruses with VE data to look at range of vaccine benefits during 2014-15 |
| moderate protection | 0.26549 |
| Vaccine effectiveness data | 0.375698 |
| genetic characterization data | 0.398484 |
| genetic properties | 0.432678 |
| protective benefits | 0.312778 |
| common flu viruses | 0.575281 |
| genetic groups | 0.463984 |
| common genetic group | 0.3122 |
| different geographic areas | 0.308149 |
| emergent flu viruses | 0.538019 |
| flu vaccination | 0.445191 |
| widespread flu activity | 0.447685 |
| 2014-2015 season | 0.313869 |
| measurable protection | 0.323377 |
| predominant H3N2 virus | 0.318088 |
| potential benefits | 0.258501 |
| H3N2 viruses | 0.602994 |
| different genetic groups | 0.380576 |
| advanced molecular diagnostics | 0.308234 |
| vaccine effectiveness | 0.39342 |
| Infectious Diseases | 0.267089 |
| flu illnesses | 0.393584 |
| vaccine’s ability | 0.32122 |
| U.S. virologic surveillance | 0.302499 |
|
| new study approach | 0.299459 |
| study sites | 0.260008 |
| high levels | 0.261708 |
| flu vaccine | 0.922464 |
| flu-associated hospitalizations | 0.264693 |
| laboratory testing data | 0.323547 |
| laboratory based methods | 0.311035 |
| outpatient illness | 0.258269 |
| flu vaccine virus | 0.521111 |
| patient VE data | 0.270089 |
| measurable benefit | 0.262739 |
| vaccine virus selection | 0.473121 |
| possible protective benefits | 0.309301 |
| seasonal flu vaccine | 0.621391 |
| flu viruses | 0.804621 |
| multiple genetic groups | 0.416124 |
| genetic characteristics | 0.265216 |
| single flu season | 0.418547 |
| 3C.3b viruses | 0.417358 |
| commonly circulating group | 0.369176 |
| flu season | 0.43262 |
| Flu VE network | 0.386779 |
| new report | 0.266742 |
| laboratory data | 0.261442 |
|
CLICK HERE |
| 16211 |
Centers for Disease Control and Prevention |
Html |
en |
Healthfulness of Foods Advertised in Small and Nontraditional Urban Stores in Minneapolis-St. Paul, Minnesota, 2014 |
Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. PCD provides an open exchange of information and knowledge among researchers, practitioners, policy makers, and others who strive to improve the health of the public through chronic disease prevention. |
| especially convenience stores | 0.436676 |
| convenience stores | 0.488751 |
| healthful food availability | 0.551838 |
| Staple Food Ordinance | 0.396595 |
| food–gas marts | 0.668984 |
| retail food stores | 0.526533 |
| small urban food | 0.413653 |
| eligible stores | 0.414326 |
| small stores | 0.478783 |
| product placements | 0.388489 |
| nontraditional food stores | 0.469099 |
| small food stores | 0.914262 |
| healthful items | 0.830583 |
| healthful products | 0.608273 |
| healthful food items | 0.565844 |
| healthful food environment | 0.51519 |
| healthful food advertisements | 0.553708 |
| nontraditional small food | 0.3903 |
| healthful checkout aisles | 0.533935 |
| food retailers | 0.498324 |
| Retail stores | 0.409804 |
| beverages | 0.406303 |
| Food Ordinance Evaluation | 0.398774 |
| store type | 0.388243 |
|
| impulse buys | 0.508645 |
| healthful advertisements | 0.501489 |
| corner stores | 0.465138 |
| healthful food | 0.765888 |
| healthful item | 0.588178 |
| healthful food products | 0.53164 |
| small food store | 0.394591 |
| dollar stores | 0.682887 |
| healthful exterior advertisement | 0.525927 |
| interior advertisements | 0.463536 |
| Small convenience stores | 0.428778 |
| small grocery stores | 0.433117 |
| impulse buy | 0.393541 |
| healthful food purchases | 0.518037 |
| urban food stores | 0.497892 |
| exterior advertisements | 0.415416 |
| food marketing | 0.387342 |
| healthful product placement | 0.528836 |
| small food retailers | 0.41781 |
| product placement | 0.832423 |
| liquor stores | 0.41449 |
| healthful foods | 0.905503 |
| store types | 0.3873 |
|
CLICK HERE |